Bortezomib in the front-line treatment of multiple myeloma

Renal function in newly diagnosed multiple myeloma - A demographic study of 1353 patients

(2010) Lene Meldgaard Knudsen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up

(2008) Rakesh Popat et al.   BRITISH JOURNAL OF HAEMATOLOGY

Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2

(2008) Mauricio Pineda-Roman et al.   BRITISH JOURNAL OF HAEMATOLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression

(2008) M.-V. Mateos et al.   HAEMATOLOGICA

Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens

(2008) Maria Roussou et al.   LEUKEMIA & LYMPHOMA

Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Drugs

(2007) William Bensinger   JOURNAL OF CLINICAL ONCOLOGY